A
$ Value
$0
Shares
202,914
Price
$0
Filed
Apr 1
Insider
Name
Carter Robert Ross
Title
Chief Financial Officer
CIK
0002039341
Roles
Officer
Transaction Details
Transaction Date
2026-03-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
436,725
Footnotes
Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates. | The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026
Filing Info
Carter Robert Ross's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-27 | TOI | A | $0 |
| 2026-03-27 | TOI | J | $62K |
| 2025-05-21 | TOI | D | $4K |
Other Insiders at TOI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Chernett Jorey | $689K | — | 2026-04-09 |
| Kaushal Mohit | — | $335K | 2026-04-16 |
|
Podnos Yale
Chief Medical Officer
|
— | — | 2026-03-27 |
|
Virnich Daniel
Chief Executive Officer
|
— | — | 2026-03-27 |
|
Carter Robert Ross
Chief Financial Officer
|
— | — | 2026-03-27 |
|
Langsam Jeffrey
Chief Clinical Officer
|
— | — | 2026-03-27 |
|
England Kristin
Chief Administrative Officer
|
— | — | 2026-03-27 |